🏛️ Verified NIH Record • Updated 2026-07-01
Understanding the Late Effects of Surviving a Pediatric Brain Tumor (NCT03208387)
Biological Substrates of Impaired Neurocognitive Functioning: Understanding the Late Effects of Surviving a Pediatric Brain Tumor
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Memorial Sloan Kettering Cancer Center
🩺 Plain-English Summary (8th-Grade Level)
The goal of this study is to learn about the cognitive and behavioral functioning of children being treated for cancer.
Who can join: Review the eligibility criteria below.
Location: Columbia University — New York, New York
Age range: 6 Years to 16 Years
🧪 Interventions in This Study
- Diffusion tensor imaging (DTI) (DIAGNOSTIC_TEST)
- Resting state functional connectivity MRI (rs-fcMRI) (DIAGNOSTIC_TEST)
- Wechsler Intelligence Scale for Children - 5th edition (WISC-V) (BEHAVIORAL)
- California Verbal Learning Test (CVLT-C) (BEHAVIORAL)
- Beery Test of Visual Motor Integration 6th edition (BEHAVIORAL)
- Grooved Pegboard (BEHAVIORAL)
- PedsQL Multidimensional Fatigue Scale (BEHAVIORAL)
- MRI (DIAGNOSTIC_TEST)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- Columbia University — New York, New York
- Memorial Sloan Kettering Cancer Center — New York, New York
- University of Texas Southwestern Medical Center — Dallas, Texas
- Seattle Children's Hospital — Seattle, Washington
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Brain Tumor
- Blood-Brain Barrier Disruption Using Transcranial MRI-Guided Focused Ultrasound — Toronto, Ontario
- Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study — Memphis, Tennessee
- Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors — Hartford, Connecticut
- Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPG — Toronto, Ontario
- Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors. — Miami, Florida
Explore by condition: All Brain Tumor clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.